Adverse events reported following live, cold-adapted, intranasal influenza vaccine.
暂无分享,去创建一个
Robert Ball | Douglas Pratt | John Iskander | M. Braun | R. Ball | J. Iskander | H. Izurieta | P. Haber | Penina Haber | R. Wise | Robert P Wise | M Miles Braun | D. Pratt | Soju Chang | C. Mink | Hector S Izurieta | ChrisAnna Mink | Soju Chang | Mph M Miles Braun
[1] N. Cox,et al. Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[2] Pedro A Piedra,et al. Live Attenuated Influenza Vaccine, Trivalent, Is Safe in Healthy Children 18 Months to 4 Years, 5 to 9 Years, and 10 to 18 Years of Age in a Community-Based, Nonrandomized, Open-Label Trial , 2005, Pediatrics.
[3] E. Lewis,et al. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents , 2004, The Pediatric infectious disease journal.
[4] Acip. Prevention and control of influenza : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2004 .
[5] R. Davis,et al. Risk of anaphylaxis after vaccination of children and adolescents. , 2003, Pediatrics.
[6] C. Bridges,et al. Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[7] Robert T. Chen,et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001. , 2003, Morbidity and mortality weekly report. Surveillance summaries.
[8] G. Redding,et al. Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma , 2002, The Pediatric infectious disease journal.
[9] Malbea A Lapete,et al. Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2004 .
[10] L. Magder,et al. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. , 1998, The New England journal of medicine.
[11] F. Varricchio,et al. The vaccine adverse event reporting system. , 1998, Journal of toxicology. Clinical toxicology.
[12] S. Rosenthal,et al. The reporting sensitivities of two passive surveillance systems for vaccine adverse events. , 1995, American journal of public health.
[13] S. Cochi,et al. The Vaccine Adverse Event Reporting System (VAERS). , 1994, Vaccine.
[14] D. Nalin. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality , 1994, The Yale Journal of Biology and Medicine.
[15] L. Kurland,et al. An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines. , 1984, American journal of epidemiology.
[16] Adverse reactions to non-steroidal antiinflammatory drugs , 1983 .